Cleared Traditional

K160571 - cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay (FDA 510(k) Clearance)

Dec 2016
Decision
294d
Days
Class 2
Risk

K160571 is an FDA 510(k) clearance for the cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay. This device is classified as a Hemoglobin A1c Test System (Class II - Special Controls, product code PDJ).

Submitted by Roche Diagnostics Operations (Rdo) (Indianapolis, US). The FDA issued a Cleared decision on December 19, 2016, 294 days after receiving the submission on February 29, 2016.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1373. Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes..

Submission Details

510(k) Number K160571 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 29, 2016
Decision Date December 19, 2016
Days to Decision 294 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code PDJ — Hemoglobin A1c Test System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1373
Definition Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes.